Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Kempharm Inc (KMPH)

6.1 -0.2 (-3.17%)

05-22 16:00

Open:

6.35

Pre. Close:

6.3

High:

6.35

Low:

6

Volume:

68,901

Market Cap:

92M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

6.358 - 6.397

6.397 - 6.425

Low:

5.909 - 5.957

5.957 - 5.991

Close:

6.036 - 6.107

6.107 - 6.157

Technical analysis  (as of: 2018-05-22 4:40:33 PM)

Overall:

      

Stoxline posted a SELL today, same as yesterday. This stock seems to continue bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.

Target:

Six months: 7.65     One year: 8.94

Support:

Support1: 5.47    Support2: 4.80

Resistance:

Resistance1: 6.55    Resistance2: 7.65

Pivot:

5.66

Moving Averages:

MA(5): 6.25     MA(20): 5.53

MA(100): 5.95     MA(250): 4.53

MACD:

MACD(12,26): 0.07     Signal(12,26,9): -0.08

%K %D:

%K(14,3): 82.85     %D(3): 83.48

RSI:

RSI(14): 54.38

52-Week:

High: 8.4  Low: 2.45  Change(%): 48.8

Average Vol(K):

3-Month: 12067  10-Days 9709

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
KMPH has closed below upper band by 30.3%. Bollinger Bands are 31.2% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

2018-05-16T16:44:42-04:00
FDA OKs first non-opioid treatment for opioid withdrawal

2018-05-14T02:50:35-04:00
KemPharm: Patients Not Liking Their Drugs Is Great News

2018-05-11T21:38:02-04:00
KemPharm's (KMPH) CEO Travis Mickle on Q1 2018 Results - Earnings Call Transcript

2018-05-10T16:31:20-04:00
KemPharm misses by $1.07

2018-05-03T00:54:16-04:00
How To Play 'Am I Diversified?' In The Pharma/Biotech Space

2018-04-26T03:18:20-04:00
Opioid prescriptions dropped 12% in 2017

2018-04-19T11:25:01-04:00
U.S. opioid prescriptions down 12% last year, largest drop in 25 years

2018-04-17T15:35:03-04:00
DEA aiming to collar production of opioids

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

NA

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

15.10

Shares Float (M)

14.80

% Held by Insiders

2.00

% Held by Institutions

33.60

Shares Short (K)

418

Shares Short Prior Month (K)

280

Stock Financials

EPS

-2.950

EPS Est. Current Year

-2.720

EPS Est. Next Year

-2.300

EPS Est. Next Quarter

-0.700

Forward EPS

-2.040

Book Value (p.s.)

162.740

PEG Ratio

Profit Margin

Operating Margin

Return on Assets (ttm)

-63.2

Return on Equity (ttm)

113.9

Qtrly Rev. Growth

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-0.838

Qtrly Earnings Growth

Operating Cash Flow (M)

-33.10

Levered Free Cash Flow (M)

-15.77

atoplab.com

Valuation

P/E

-2.07

P/E Growth Ratio

-0.03

P/BV

0.04

P/S

P/CF

-2.78

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.